SUBSCRIBE
SUBSCRIBE

Seaport Therapeutics

NEWS
Art collage, hands and falling coins in orange circle. Modern design of finance and business.
Funding
Seaport, Six Months Out of Stealth, Comes Back for $225M Raise
Seaport Therapeutics, kick started by the former leaders of Karuna Therapeutics, has raised $225 million in an oversubscribed Series B to fund a pipeline of neuropsychiatric medicines.
October 21, 2024
 · 
1 min read
 · 
Annalee Armstrong
IN THE PRESS
Press Releases
Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
December 11, 2024
 · 
4 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
December 11, 2024
 · 
8 min read
Press Releases
Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
November 20, 2024
 · 
3 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
November 20, 2024
 · 
6 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
November 6, 2024
 · 
6 min read
Press Releases
Seaport Therapeutics Names Lauren White as Chief Financial Officer
November 5, 2024
 · 
3 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
October 21, 2024
 · 
11 min read
Press Releases
Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
October 21, 2024
 · 
5 min read
Business
Seaport Therapeutics Appoints Seasoned Executives to Management Team
June 18, 2024
 · 
5 min read
Business
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
June 18, 2024
 · 
10 min read
Load More
JOBS